Dual-filament regulation of contraction in fast and slow human skeletal muscle fibres

MRC · United Kingdom government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Skeletal muscle weakness is a major feature of many muscle disorders, yet there are currently no effective treatments to restore muscle contractility. This lack of therapeutic options reflects a limited understanding of the molecular mechanisms that regulate contraction in human skeletal muscle.
Traditionally, muscle contraction is controlled by calcium-dependent activation of the thin filament: following electrical stimulation, calcium ions released from the sarcoplasmic reticulum bind to troponin, triggering structural changes that enable actin filaments to interact with myosin motors on the thick filament, producing force and movement. However, recent evidence indicates that the thick filament itself plays a fundamental regulatory role in contraction. Calcium-independent mechanisms within the myosin filament control the transition of myosin motors between OFF and ON states, regulating force generation. So far, these newly identified mechanisms have been characterised only in “fast-contracting” fibres in animal models, whereas little is known about the two main fibre types of human skeletal muscle, the “slow-contracting” type-1 and the fast type-2A fibres.
Our preliminary findings suggest that thick filament-based regulatory mechanisms operate differently in human muscle fibres compared to previously studied models. Disruption of these mechanisms is already implicated in sarcomere-based cardiomyopathies. Moreover, small molecules that modulate myosin motor ON/OFF transitions have recently been developed to treat those heart diseases, demonstrating the feasibility of pharmacologically restoring contractile function. Although these myosin modulators also target the slow myosin in skeletal muscle, their effects on skeletal muscle regulation, and their therapeutic potential in muscle disorders, remain largely unexplored.
The overarching aim of this project is to define the fundamental regulatory mechanisms controlling human skeletal muscle contractility, in both...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedDecember 31, 2025
Procurement stageActive solicitation
ClosedClosing date not published
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Browse Similar Open Opportunities in United Kingdom

Global Travel, Accommodation and Venue Management Services
NEPRO Total Talent
Capital Programme Delivery Framework(s)
Workforce Solution 2
Technology Products and Associated Services 3
Technology Products and Associated Services 3
GMCA 2201 NW Regional Children’s Services Contract
Integrated Partnerships Framework

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.